RBC Capital Maintains Outperform on Praxis Precision Medicine, Raises Price Target to $462

Benzinga · 1d ago
RBC Capital analyst Leonid Timashev maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Outperform and raises the price target from $449 to $462.